The Wall Street Journal Reported Ligand Pharmaceuticals Is Buying Xoma for $39/Share In Cash

Benzinga Newsdesk www.benzinga.com Neutral 92.5%

Neg 0% Neu 92.5% Pos 0%

Comments

No comments yet. Be the first!